Why understanding metabolism matters
Drugs to treat cancer have actually been able to cure 90% of childhood leukemias; 60-85% of certain kinds of lymphomas; a very high percentage of testicular cancers; and a few other uncommon cancers.
The problem is that these cures are of rare cancers all with unusual behaviors. (They represent cancers from just a few gene mutations--notice that they tend to be in younger people). The vast majority of cancers that afflict humankind are in older individuals and have multiple complex mutation patterns. This much larger group of cancers are generally NOT curable.
But despite their genetic complexity, these cancers most often have a common metabolic feature---they are glucose/glycolytically dependent for their energy supply.
We're targeting precisely this common glycolytic metabolic feature in our effort to contain cancer with less toxic treatments. In our cell culture experiments we've shown that ketone bodies can compete with glucose within cancer cells inhibiting their growth. We've also shown in our pilot human RECHARGE trial that people in ketosis may be responsive too. Let's keep pushing to bring these therapies closer to reality.
3 comments